Trial Profile
Single Patient Treatment Study for the Use of XL999 Administered Intravenously to a Subject With Advanced Malignancies Previously Enrolled in Study XL999-900
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs XL 999 (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 27 Sep 2013 New trial record